Maxygen, Inc. (NASDAQ:MAXY)

CAPS Rating: 4 out of 5

A biotechnology company committed to the discovery and development of improved next-generation protein pharmaceuticals for the treatment of disease and serious medical conditions.

Recs

0
Player Avatar Salamatgod (< 20) Submitted: 5/19/2008 12:34:01 PM : Underperform Start Price: $4.63 MAXY Score: -31.38

yea going down

Featured Broker Partners


Advertisement